Jin YN - Search Results

1

Concurrent chemoradiotherapy with or without neoadjuvant chemotherapy in pediatric patients with stage III-IVa nasopharyngeal carcinoma: a real-world propensity score-matched cohort study.

Jin YN, Ruan ZH, Cao WW, Yang L, Yao W, Pei XF, Zhang WJ, Marks T, Yao JJ, Xia LP. Jin YN, et al. J Cancer Res Clin Oncol. 2023 Oct;149(13):11929-11940. doi: 10.1007/s00432-023-05041-1. Epub 2023 Jul 7. J Cancer Res Clin Oncol. 2023. PMID: 37418058

2

Predictors of Mastoiditis after Intensity-Modulated Radiotherapy in Nasopharyngeal Carcinoma: A Dose-Volume Analysis.

Yao JJ, Zhou GQ, Jin YN, Zhang WJ, Lin L, Yu XL, Shao JY, Ma J, Sun Y. Yao JJ, et al. Among authors: jin yn. J Cancer. 2016 Jan 8;7(3):276-82. doi: 10.7150/jca.13183. eCollection 2016. J Cancer. 2016. PMID: 26918040 Free PMC article.

3

Is pretreatment Epstein-Barr virus DNA still associated with 6-year survival outcomes in locoregionally advanced nasopharyngeal carcinoma?

Jin YN, Yao JJ, Zhang F, Wang SY, Zhang WJ, Zhou GQ, Qi ZY, Sun Y. Jin YN, et al. J Cancer. 2017 Mar 12;8(6):976-982. doi: 10.7150/jca.18124. eCollection 2017. J Cancer. 2017. PMID: 28529609 Free PMC article.

4

The Effect of Adding Neoadjuvant Chemotherapy to Concurrent Chemoradiotherapy in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma and Undetectable Pretreatment Epstein-Barr Virus DNA.

Jin YN, Yao JJ, Wang SY, Zhang WJ, Zhang F, Zhou GQ, Cheng ZB, Mo HY, Sun Y. Jin YN, et al. Transl Oncol. 2017 Aug;10(4):527-534. doi: 10.1016/j.tranon.2017.03.007. Epub 2017 May 29. Transl Oncol. 2017. PMID: 28570869 Free PMC article.

5

Prognostic value of serum Epstein-Barr virus antibodies in patients with nasopharyngeal carcinoma and undetectable pretreatment Epstein-Barr virus DNA.

Yao JJ, Lin L, Jin YN, Wang SY, Zhang WJ, Zhang F, Zhou GQ, Cheng ZB, Qi ZY, Sun Y. Yao JJ, et al. Among authors: jin yn. Cancer Sci. 2017 Aug;108(8):1640-1647. doi: 10.1111/cas.13296. Epub 2017 Jul 13. Cancer Sci. 2017. PMID: 28603915 Free PMC article.

6

Prognostic value of primary gross tumor volume and standardized uptake value of ¹⁸F-FDG in PET/CT for distant metastasis in locoregionally advanced nasopharyngeal carcinoma.

Jin YN, Yao JJ, Wang SY, Zhang WJ, Zhou GQ, Zhang F, Cheng ZB, Ma J, Mo HY, Sun Y. Jin YN, et al. Tumour Biol. 2017 Jul;39(7):1010428317717843. doi: 10.1177/1010428317717843. Tumour Biol. 2017. PMID: 28671052 Free article.

7

Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.

Yao JJ, Zhou GQ, Wang YQ, Wang SY, Zhang WJ, Jin YN, Zhang F, Li L, Liu LZ, Cheng ZB, Ma J, Qi ZY, Sun Y. Yao JJ, et al. Among authors: jin yn. Chin J Cancer. 2017 Dec 29;36(1):98. doi: 10.1186/s40880-017-0264-x. Chin J Cancer. 2017. PMID: 29284539 Free PMC article.

8

The Characteristics and Survival Outcomes in Patients Aged 70 Years and Older with Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy Era.

Jin YN, Zhang WJ, Cai XY, Li MS, Lawrence WR, Wang SY, Mai DM, Du YY, Luo DH, Mo HY. Jin YN, et al. Cancer Res Treat. 2019 Jan;51(1):34-42. doi: 10.4143/crt.2017.551. Epub 2018 Feb 6. Cancer Res Treat. 2019. PMID: 29409313 Free PMC article.

9

The detrimental effects of radiotherapy interruption on local control after concurrent chemoradiotherapy for advanced T-stage nasopharyngeal carcinoma: an observational, prospective analysis.

Yao JJ, Jin YN, Wang SY, Zhang F, Zhou GQ, Zhang WJ, Zhi-Bin, Cheng, Ma J, Qi ZY, Sun Y. Yao JJ, et al. Among authors: jin yn. BMC Cancer. 2018 Jul 16;18(1):740. doi: 10.1186/s12885-018-4495-2. BMC Cancer. 2018. PMID: 30012115 Free PMC article.

10

Do all patients with advanced N-stage nasopharyngeal carcinoma benefit from the addition of induction chemotherapy to concurrent chemoradiotherapy?

Yao JJ, Jin YN, Liu ZG, Liu QD, Pei XF, Zhou HL, Zhang WJ, Zhang F, Lin L, Lawrence WR, Wang SY, Ma J, Zhou GQ, Sun Y. Yao JJ, et al. Among authors: jin yn. Ther Adv Med Oncol. 2019 Mar 21;11:1758835919833863. doi: 10.1177/1758835919833863. eCollection 2019. Ther Adv Med Oncol. 2019. PMID: 30923578 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

84 results

Search Page